Rapport Therapeutics, Inc.
Returns on Capital
| Period | ROE | ROI | ROA |
|---|---|---|---|
| Mar 2023 | 153.8% | 153.8% | — |
| Jun 2023 | 68.0% | 68.0% | — |
| Sep 2023 | 66.4% | 66.4% | — |
| Dec 2023 | 52.7% | 52.7% | -8.7% |
| Mar 2024 | 57.2% | 57.2% | — |
| Jun 2024 | -5.4% | -5.4% | -5.2% |
| Sep 2024 | -5.4% | -5.4% | -5.3% |
| Dec 2024 | -6.5% | -6.5% | -6.3% |
| Mar 2025 | -8.4% | -8.4% | -8.0% |
| Jun 2025 | -10.1% | -10.1% | -9.4% |
| Sep 2025 | -5.3% | -5.3% | -5.0% |
| Dec 2025 | -7.0% | -7.0% | -6.6% |
| Mar 2026 | -4.2% | -4.2% | -4.0% |
| Jun 2026 | -13.4% | -13.4% | -12.3% |